163 related articles for article (PubMed ID: 19890961)
1. Protein phosphatase 2A subunit gene haplotypes and proliferative breast disease modify breast cancer risk.
Dupont WD; Breyer JP; Bradley KM; Schuyler PA; Plummer WD; Sanders ME; Page DL; Smith JR
Cancer; 2010 Jan; 116(1):8-19. PubMed ID: 19890961
[TBL] [Abstract][Full Text] [Related]
2. A genetic variant in a PP2A regulatory subunit encoded by the PPP2R2B gene associates with altered breast cancer risk and recurrence.
Vazquez A; Kulkarni D; Grochola LF; Bond GL; Barnard N; Toppmeyer D; Levine AJ; Hirshfield KM
Int J Cancer; 2011 May; 128(10):2335-43. PubMed ID: 20669227
[TBL] [Abstract][Full Text] [Related]
3. Functional genetic polymorphisms in PP2A subunit genes confer increased risks of lung cancer in southern and eastern Chinese.
Yang R; Yang L; Qiu F; Zhang L; Wang H; Yang X; Deng J; Fang W; Zhou Y; Lu J
PLoS One; 2013; 8(10):e77285. PubMed ID: 24204789
[TBL] [Abstract][Full Text] [Related]
4. Functional importance of PP2A regulatory subunit loss in breast cancer.
Watt LF; Panicker N; Mannan A; Copeland B; Kahl RGS; Dun MD; Young B; Roselli S; Verrills NM
Breast Cancer Res Treat; 2017 Nov; 166(1):117-131. PubMed ID: 28744751
[TBL] [Abstract][Full Text] [Related]
5. Identification and functional analysis of variant haplotypes in the 5'-flanking region of protein phosphatase 2A-Bδ gene.
Chen HF; Lin LN; Chen YX; Wan JX; Luo J; Zhang CZ; Li XJ; Hu YM; Mai JR; Chen W; Lin ZN; Lin YC
PLoS One; 2012; 7(4):e35524. PubMed ID: 22539979
[TBL] [Abstract][Full Text] [Related]
6. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.
Kabat GC; Jones JG; Olson N; Negassa A; Duggan C; Ginsberg M; Kandel RA; Glass AG; Rohan TE
Cancer Causes Control; 2010 Jun; 21(6):821-8. PubMed ID: 20084540
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional analyses of polymorphism haplotypes of protein phosphatase 2A-Aα gene promoter.
Lin YC; Chen HF; Lin LN; Luo J; Li W; Zhang SJ; Li XJ; Hu YM; Chen YX; Chen W; Lin ZN
Mutat Res; 2011 Nov; 716(1-2):66-75. PubMed ID: 21889517
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease.
Theendakara V; Bredesen DE; Rao RV
Mol Cell Neurosci; 2017 Sep; 83():83-91. PubMed ID: 28720530
[TBL] [Abstract][Full Text] [Related]
9. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ
Cancer; 2006 Sep; 107(6):1240-7. PubMed ID: 16902983
[TBL] [Abstract][Full Text] [Related]
10. PPP2R5D-Related Intellectual Disability and Neurodevelopmental Delay: A Review of the Current Understanding of the Genetics and Biochemical Basis of the Disorder.
Biswas D; Cary W; Nolta JA
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32074998
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and differential expression patterns of the regulatory subunit B' gene of PP2A in goldfish, Carassius auratus.
Fu H; Ma H; Zheng C; Lü J; Yu X; Li C; Peng Y; Liao G; Liu W; Xiao Y; Liu Y; Li DW
Sci China C Life Sci; 2009 Aug; 52(8):724-32. PubMed ID: 19727590
[TBL] [Abstract][Full Text] [Related]
12. The glycine 90 to aspartate alteration in the Abeta subunit of PP2A (PPP2R1B) associates with breast cancer and causes a deficit in protein function.
Esplin ED; Ramos P; Martinez B; Tomlinson GE; Mumby MC; Evans GA
Genes Chromosomes Cancer; 2006 Feb; 45(2):182-90. PubMed ID: 16276521
[TBL] [Abstract][Full Text] [Related]
13. HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer.
Stark A; Hulka BS; Joens S; Novotny D; Thor AD; Wold LE; Schell MJ; Melton LJ; Liu ET; Conway K
J Clin Oncol; 2000 Jan; 18(2):267-74. PubMed ID: 10637239
[TBL] [Abstract][Full Text] [Related]
14. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms.
Calin GA; di Iasio MG; Caprini E; Vorechovsky I; Natali PG; Sozzi G; Croce CM; Barbanti-Brodano G; Russo G; Negrini M
Oncogene; 2000 Feb; 19(9):1191-5. PubMed ID: 10713707
[TBL] [Abstract][Full Text] [Related]
15. Genetic Variant of PP2A Subunit Gene Confers an Increased Risk of Primary Liver Cancer in Chinese.
Wang Y; Huang Q; Huang X; Zhao H; Guan B; Ban K; Zhu X; Ma Z; Tang Y; Su Z; Nong Q
Pharmgenomics Pers Med; 2021; 14():1565-1574. PubMed ID: 34898995
[TBL] [Abstract][Full Text] [Related]
16. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
[TBL] [Abstract][Full Text] [Related]
17. Atypical Protein Phosphatase 2A Gene Families Do Not Expand via Paleopolyploidization.
Booker MA; DeLong A
Plant Physiol; 2017 Feb; 173(2):1283-1300. PubMed ID: 28034953
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth.
Loveday C; Tatton-Brown K; Clarke M; Westwood I; Renwick A; Ramsay E; Nemeth A; Campbell J; Joss S; Gardner M; Zachariou A; Elliott A; Ruark E; van Montfort R; ; Rahman N
Hum Mol Genet; 2015 Sep; 24(17):4775-9. PubMed ID: 25972378
[TBL] [Abstract][Full Text] [Related]
19. The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation.
Dzulko M; Pons M; Henke A; Schneider G; Krämer OH
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188453. PubMed ID: 33068647
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants for PP2A substrate specificity: charged residues mediate dephosphorylation of tyrosine hydroxylase by the PP2A/B' regulatory subunit.
Saraf A; Oberg EA; Strack S
Biochemistry; 2010 Feb; 49(5):986-95. PubMed ID: 20017541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
